632 related articles for article (PubMed ID: 35464057)
1. Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M; Li Y; Li S; Lv J
Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
[TBL] [Abstract][Full Text] [Related]
2. Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
Evangelista I; Nuti R; Picchioni T; Dotta F; Palazzuoli A
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269778
[TBL] [Abstract][Full Text] [Related]
3. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.
Pan KL; Hsu YC; Chang ST; Chung CM; Lin CL
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239956
[TBL] [Abstract][Full Text] [Related]
4. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Jia G; Hill MA; Sowers JR
Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
Prandi FR; Evangelista I; Sergi D; Palazzuoli A; Romeo F
Heart Fail Rev; 2023 May; 28(3):597-606. PubMed ID: 35001338
[TBL] [Abstract][Full Text] [Related]
6. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
Khan S; Ahmad SS; Kamal MA
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.
Knapp M; Tu X; Wu R
Acta Pharmacol Sin; 2019 Jan; 40(1):1-8. PubMed ID: 29867137
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
Nakamura K; Miyoshi T; Yoshida M; Akagi S; Saito Y; Ejiri K; Matsuo N; Ichikawa K; Iwasaki K; Naito T; Namba Y; Yoshida M; Sugiyama H; Ito H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408946
[TBL] [Abstract][Full Text] [Related]
9. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
Falcão-Pires I; Leite-Moreira AF
Heart Fail Rev; 2012 May; 17(3):325-44. PubMed ID: 21626163
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Diabetes Induction on the Rat Heart: Differences in Oxidative Stress, Inflammatory Cells, and Fibrosis between Subendocardial and Interstitial Myocardial Areas.
Guido MC; Marques AF; Tavares ER; Tavares de Melo MD; Salemi VMC; Maranhão RC
Oxid Med Cell Longev; 2017; 2017():5343972. PubMed ID: 28781721
[TBL] [Abstract][Full Text] [Related]
11. The role of hyperglycaemia in the development of diabetic cardiomyopathy.
El Hayek MS; Ernande L; Benitah JP; Gomez AM; Pereira L
Arch Cardiovasc Dis; 2021 Nov; 114(11):748-760. PubMed ID: 34627704
[TBL] [Abstract][Full Text] [Related]
12. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
[TBL] [Abstract][Full Text] [Related]
13. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
14. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
Ansari M; Gopalakrishnan S; Kurian GA
J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
[TBL] [Abstract][Full Text] [Related]
15. Oxidative Stress Signaling Mediated Pathogenesis of Diabetic Cardiomyopathy.
Tang Z; Wang P; Dong C; Zhang J; Wang X; Pei H
Oxid Med Cell Longev; 2022; 2022():5913374. PubMed ID: 35103095
[TBL] [Abstract][Full Text] [Related]
16. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
Xu Z; Sun J; Tong Q; Lin Q; Qian L; Park Y; Zheng Y
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941647
[TBL] [Abstract][Full Text] [Related]
17. Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.
Mandavia CH; Aroor AR; Demarco VG; Sowers JR
Life Sci; 2013 Mar; 92(11):601-8. PubMed ID: 23147391
[TBL] [Abstract][Full Text] [Related]
18. Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.
Peng ML; Fu Y; Wu CW; Zhang Y; Ren H; Zhou SS
Front Endocrinol (Lausanne); 2022; 13():907757. PubMed ID: 35784531
[TBL] [Abstract][Full Text] [Related]
19. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
Dhalla NS; Shah AK; Tappia PS
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
[TBL] [Abstract][Full Text] [Related]
20. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
